BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28578348)

  • 1. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
    Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
    World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
    Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
    J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
    Wei S; Dai M; Zhang C; Teng K; Wang F; Li H; Sun W; Feng Z; Kang T; Guan X; Xu R; Cai M; Xie D
    Protein Cell; 2021 Oct; 12(10):788-809. PubMed ID: 32748349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma.
    Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M
    Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.
    Yang Y; Zhang N; Zhu J; Hong XT; Liu H; Ou YR; Su F; Wang R; Li YM; Wu Q
    Int J Oncol; 2017 Jun; 50(6):1977-1988. PubMed ID: 28498415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
    Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
    J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein promotes the stem-like properties of OV6
    Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
    Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.
    Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.